Prostate Adenocarcinoma without Neuroendocrine Differentiation

Prostate Adenocarcinoma without Neuroendocrine Differentiation — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03360721	Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer	terminated	Phase 2	7	M.D. Anderson Cancer CenterOTHER	1	Mar 16, 2026	clinicaltrials
NCT03570476	Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer	terminated	Phase 2	2	University of WashingtonOTHER	1	Sep 21, 2020	clinicaltrials